Back to REGN
Rhenman & Partners Asset Management AB → REGN
Rhenman & Partners Asset Management AB REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$14.7M
Q3 2026
Peak value
$47.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $47.4M |
| Q1 2026 | $37.2M |
| Q2 2026 | $17.1M |
| Q3 2026 | $14.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $14.7M | 19.3K | — | — |
| Q2 2026 | $17.1M | 27.4K | — | — |
| Q1 2026 | $37.2M | 48.1K | — | — |
| Q4 2025 | $47.4M | 61.4K | — | — |